What to Expect on Semaglutide: Week by Week Timeline

Many people report a noticeable reduction in hunger and food noise within the first week at the starting dose. Portion sizes at meals often decrease naturally without a sense of deprivation. Some mild gastrointestinal effects such as nausea are commonly reported during this initial adjustment, typically resolving within a few days.

Initial weight changes during the first month are commonly reported, often ranging from modest to moderate depending on starting weight and caloric changes. The reduction in cravings and between-meal snacking is frequently described as the most impactful early change. Dose titration during this period means the effects are still building toward their full potential.

This is the phase where many people reach a therapeutic dose and begin seeing the most consistent results. Patients often describe a fundamentally different relationship with food, including reduced interest in high-calorie choices. Blood sugar markers in those with metabolic concerns have been associated with improvement during this window.

Weight management progress typically continues at a steady pace through months four to six. Many people report that the lifestyle changes initiated by appetite reduction begin to feel habitual and self-sustaining. Energy levels and physical activity tolerance are commonly described as improved due to reduced body weight.

Some individuals experience a slowing of weight changes around the six-month mark, which is a normal physiological response. Providers often adjust dosing or incorporate complementary strategies at this stage. Long-term metabolic benefits including cardiovascular markers have been associated with sustained use over this timeframe.